articleJournal of Clinical InvestigationSep 1, 2003GREEN OA

FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

University of L'Aquila · National Institutes of Health · +3 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

FGF-23, a novel member of the FGF family, is the product of the gene mutated in autosomal dominant hypophosphatemic rickets (ADHR). FGF-23 has been proposed as a circulating factor causing renal phosphate wasting not only in ADHR (as a result of inadequate degradation), but also in tumor-induced osteomalacia (as a result of excess synthesis by tumor cells). Renal phosphate wasting occurs in approximately 50% of patients with McCune-Albright syndrome (MAS) and fibrous dysplasia of bone (FD), which result from postzygotic mutations of the GNAS1 gene. We found that FGF-23 is produced by normal and FD osteoprogenitors and bone-forming cells in vivo and in vitro. In situ hybridization analysis of FGF-23 mRNA…

Citation impact

646
total citations
FWCI
14.98
Percentile
100%
References
47
Citations per year

Authors

12

Topics & keywords

Keywords
  • Fibrous dysplasia
  • Osteomalacia
  • Wasting
  • Fibroblast growth factor 23
  • Internal medicine
  • Endocrinology
  • GNAS complex locus
  • Bone disease
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding